Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 20 Aug 2018
At a glance
- Drugs Sitafloxacin (Primary) ; Ertapenem
- Indications Urinary tract infections
- Focus Therapeutic Use
- 10 Aug 2018 Planned End Date changed from 1 Dec 2018 to 1 Jan 2019.
- 10 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jan 2019.
- 21 Aug 2017 New trial record